JACOBIO-B repurchases 87,300 shares for HK$0.46 million; treasury stock rises to 7.50 million shares

Bulletin Express05-21 21:03

Jacobio Pharmaceuticals Group Co., Ltd. (JACOBIO-B) disclosed that on 21 May 2026 it bought back 87,300 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$5.30 to HK$5.31 per share. The volume-weighted average repurchase price was HK$5.303265, bringing the total cash outlay to HK$0.46 million.

Following the transaction: • Issued shares (excluding treasury shares) decreased by 0.011 % to 784.26 million. • Treasury shares increased to 7.50 million, while the company’s total issued shares remained unchanged at 791.76 million.

Repurchases are being executed under the mandate approved on 10 June 2025, which authorises the company to buy back up to 78.87 million shares. Cumulative repurchases under this mandate now total 4.48 million shares, equivalent to 0.568 % of the issued share base on the mandate’s reference date.

Under Hong Kong listing rules, Jacobio is subject to a moratorium on issuing new shares or transferring treasury shares until 20 June 2026. The company confirmed that the buyback complied with all relevant Main Board requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112910727?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112910727","market":"us","top_or_hot":-1,"title":"JACOBIO-B repurchases 87,300 shares for HK$0.46 million; treasury stock rises to 7.50 million shares","media":"Bulletin Express","content":"<p>Jacobio Pharmaceuticals Group Co., Ltd. (JACOBIO-B) disclosed that on 21 May 2026 it bought back 87,300 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$5.30 to HK$5.31 per share. The volume-weighted average repurchase price was HK$5.303265, bringing the total cash outlay to HK$0.46 million.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury shares) decreased by 0.011 % to 784.26 million.  \n• Treasury shares increased to 7.50 million, while the company’s total issued shares remained unchanged at 791.76 million.</p>\n<p>Repurchases are being executed under the mandate approved on 10 June 2025, which authorises the company to buy back up to 78.87 million shares. Cumulative repurchases under this mandate now total 4.48 million shares, equivalent to 0.568 % of the issued share base on the mandate’s reference date.</p>\n<p>Under Hong Kong listing rules, Jacobio is subject to a moratorium on issuing new shares or transferring treasury shares until 20 June 2026. The company confirmed that the buyback complied with all relevant Main Board requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JACOBIO-B repurchases 87,300 shares for HK$0.46 million; treasury stock rises to 7.50 million shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJACOBIO-B repurchases 87,300 shares for HK$0.46 million; treasury stock rises to 7.50 million shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-21 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jacobio Pharmaceuticals Group Co., Ltd. (JACOBIO-B) disclosed that on 21 May 2026 it bought back 87,300 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$5.30 to HK$5.31 per share. The volume-weighted average repurchase price was HK$5.303265, bringing the total cash outlay to HK$0.46 million.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury shares) decreased by 0.011 % to 784.26 million.  \n• Treasury shares increased to 7.50 million, while the company’s total issued shares remained unchanged at 791.76 million.</p>\n<p>Repurchases are being executed under the mandate approved on 10 June 2025, which authorises the company to buy back up to 78.87 million shares. Cumulative repurchases under this mandate now total 4.48 million shares, equivalent to 0.568 % of the issued share base on the mandate’s reference date.</p>\n<p>Under Hong Kong listing rules, Jacobio is subject to a moratorium on issuing new shares or transferring treasury shares until 20 June 2026. The company confirmed that the buyback complied with all relevant Main Board requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01167","symbol_name":"加科思-B","start_time":0,"source_url":"","article_id":"1112910727","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112910727","pubTimestamp":1779368607,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jacobio Pharmaceuticals Group Co., Ltd. (JACOBIO-B) disclosed that on 21 May 2026 it bought back 87,300 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$5.30 to HK$5.31 per...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01167":"加科思-B"},"translate_title":"JACOBIO-B回购8.73万股，作价0.46万港元；库存股增至750万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01167":1},"content_text":"Jacobio Pharmaceuticals Group Co., Ltd. (JACOBIO-B) disclosed that on 21 May 2026 it bought back 87,300 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$5.30 to HK$5.31 per share. The volume-weighted average repurchase price was HK$5.303265, bringing the total cash outlay to HK$0.46 million.\nFollowing the transaction:\n• Issued shares (excluding treasury shares) decreased by 0.011 % to 784.26 million.  \n• Treasury shares increased to 7.50 million, while the company’s total issued shares remained unchanged at 791.76 million.\nRepurchases are being executed under the mandate approved on 10 June 2025, which authorises the company to buy back up to 78.87 million shares. Cumulative repurchases under this mandate now total 4.48 million shares, equivalent to 0.568 % of the issued share base on the mandate’s reference date.\nUnder Hong Kong listing rules, Jacobio is subject to a moratorium on issuing new shares or transferring treasury shares until 20 June 2026. The company confirmed that the buyback complied with all relevant Main Board requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112910727","isCrawlerRequest":true}